The !5.2million (£4million) Nanomal project – launched today – is planning to provide an affordable hand-held diagnostic device to swiftly detect malaria infection and parasites’ drug resistance.
It was set up in response to increasing signs that the malaria parasite is mutating to resist the most powerful class of anti-malaria drugs, artemisinins. The European Commission has awarded !4million (£3.1million) to the project.